| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2027 ( Subtotal = -$586,669 ) |
| | 2027 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA258776 | Pan-Cancer characterization of 3’UTR somatic mutations controlling tumor immune evasion | 000 | 5 | NIH | 11/6/2026 | $0 |
| | 2027 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01NS149672 | Meningeal Sensory Neuroimmune Interactions Underlying Migraine Headache | 000 | 1 | NIH | 11/6/2026 | -$66,237 |
| | 2027 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01MH127174 | Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services (BICEPS) | 000 | 5 | NIH | 11/6/2026 | $0 |
| | 2027 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01NS115972 | Cortical-Meningeal Interactions Underlying Migraine Headache | 000 | 5 | NIH | 11/9/2026 | $0 |
| | 2027 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL180838 | ADAMTS13 in Human Health and Disease | 000 | 1 | NIH | 10/22/2026 | $0 |
| | 2027 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA310856 | Overcoming Resistance to EGFR Tyrosine Kinase Inhibitors in Lung Cancer | 000 | 1 | NIH | 10/20/2026 | $0 |
| | 2027 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA258442 | Clinical characterization of Kidney Injury Molecule-1 (KIM-1) as a Biomarker in Renal Cell Carcinoma | 000 | 5 | NIH | 10/8/2026 | $0 |
| | 2027 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL178894 | Real-World Effectiveness and Value of Glucagon-Like Peptide-1 Receptor Agonists for Prevention of Cardiovascular Disease | 000 | 1 | NIH | 11/4/2026 | $0 |
| | 2027 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AT013324 | Assessing the Efficacy of Mindfulness Apps | 000 | 1 | NIH | 11/5/2026 | $0 |
| | 2027 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL178578 | Serotonergic circuit mechanisms to enhance upper airway tone and respiration in the setting of opioids and sleep-disordered breathing. | 000 | 1 | NIH | 11/3/2026 | $0 |
| | 2027 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AT013324 | Assessing the Efficacy of Mindfulness Apps | 000 | 1 | NIH | 11/5/2026 | $0 |
| | 2027 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K08HL181191 | Vascular Piezo1 in Thrombosis | 000 | 1 | NIH | 11/5/2026 | $0 |
| | 2027 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK130929 | Corticosteroids to Reduce Inflammation in Severe Pancreatitis (CRISP) | 000 | 5 | NIH | 11/5/2026 | $0 |
| | 2027 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AI085567 | Expanded Double Negative T cells in SLE. | 000 | 15 | NIH | 10/15/2026 | -$5,461 |
| | 2027 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | U54HL165440 | Multi-scale Spatial Mapping of Human Lymphatic Vessels | 000 | 4 | NIH | 11/2/2026 | $0 |
| | 2027 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK127575 | Post-translational control of adipose tissue remodeling and metabolic health | 000 | 5 | NIH | 11/12/2026 | -$13,440 |
| | 2027 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | U54HL165440 | Multi-scale Spatial Mapping of Human Lymphatic Vessels | 000 | 4 | NIH | 11/2/2026 | $0 |
| | 2027 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA249223 | Pentraxin-3 in the Pathogenesis and Management of Triple-Negative Breast Cancer | 000 | 5 | NIH | 11/4/2026 | -$5,386 |
| | 2027 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K01DK128075 | Mechanisms for the regulation of novel lipids in vivo | 000 | 5 | NIH | 10/22/2026 | $0 |
| | 2027 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AI149670 | Single-Cell Analysis of the HIV/SIV Reservoir | 000 | 5 | NIH | 10/15/2026 | $0 |
| | 2027 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | RC2DK122397 | Integrating large scale genomics and functional studies to accelerate FSGS/NS discovery | 000 | 5 | NIH | 10/26/2026 | -$15,824 |
| | 2027 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | RC2DK122397 | Integrating large scale genomics and functional studies to accelerate FSGS/NS discovery | 000 | 5 | NIH | 10/26/2026 | -$276,644 |
| | 2027 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R03TR004808 | The Interaction Between the Thyroid Axis and Brown Adipose Tissue in Humans | 000 | 1 | NIH | 11/4/2026 | $0 |
| | 2027 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK126674 | Role of Ectonucleotidase in Voiding Function and Dysfunction | 000 | 4 | NIH | 10/26/2026 | -$1,436 |
| | 2027 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HS029781 | The Epidemiology of Diagnostic Error in Emergency Care in the United States and the Association with Patient Outcomes and Healthcare Costs | 000 | 2 | AHRQ | 10/30/2026 | -$193,431 |
| | 2027 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL154744 | Gadolinium Free Cardiac MR Imaging of Scar and Fibrosis | 000 | 4 | NIH | 10/22/2026 | -$8,811 |
|
 | Issue Date FY: 2026 ( Subtotal = $144,971,978 ) (Continued on the next page) |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | DP2AI184811 | Host-Dependent Mechanisms that Guide the Longitudinal Dynamic of Sites of SIV Integration | 000 | 3 | NIH | 7/24/2026 | $518,700 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK138529 | A liver-specific mitochondrial carrier that controls energy homeostasis | 001 | 3 | NIH | 7/20/2026 | $1,056,633 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | U01IP001257 | IP24-045, A Prospective Observational Study of Respiratory Virus Epidemiology in the Greater Boston Area | 01 | 3 | CDC | 7/30/2026 | $0 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | U01IP001257 | IP24-045, A Prospective Observational Study of Respiratory Virus Epidemiology in the Greater Boston Area | 00 | 3 | CDC | 7/20/2026 | $2,670,000 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA293050 | Multispectral imaging of bile duct epithelial morphology for early detection of malignancy | 000 | 3 | NIH | 6/10/2026 | $705,508 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL175300 | Leveraging Large Linked Datasets and Novel Analytic Methods to Understand the Long-term Effectiveness and Value of Cardiac Rehabilitation in Understudied Populations | 000 | 3 | NIH | 7/7/2026 | $721,288 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AT012166 | Mindful Steps: A Web-Based Mind-Body Exercise Intervention to Promote Physical Activity in Chronic Cardiopulmonary Disease | 000 | 3 | NIH | 5/4/2026 | $806,077 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K23NS124656 | Non-Invasive Seizure Forecasting System Using E-Diaries, Internal and External Factors | 000 | 5 | NIH | 6/3/2026 | $187,230 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HD109794 | Down Syndrome: a potential treatment XISTs | 001 | 3 | NIH | 8/17/2026 | $564,755 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL163172 | Hemopexin as an Early Biomarker of Anthracycline Cardiac Toxicity | 000 | 5 | NIH | 5/18/2026 | $633,596 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | T32HL160522 | Training Program in Cardiovascular Research | 000 | 5 | NIH | 9/17/2026 | $514,996 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K23HL183890 | Integrating Policy and Community-Based Strategies to Improve GLP-1RA Access for Low-Income Adults with Obesity | 000 | 1 | NIH | 7/16/2026 | $169,504 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK133223 | Regulation of Lipolysis by Oxytocin | 000 | 4 | NIH | 6/9/2026 | $556,388 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA266704 | Enhancing the Efficacy of Docetaxel in Prostate Cancer | 000 | 5 | NIH | 7/28/2026 | $654,537 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | UM1AI164556 | I4C 2.0: Immunotherapy for Cure | 003 | 6 | NIH | 8/1/2026 | $166,667 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | UM1AI164556 | I4C 2.0: Immunotherapy for Cure | 003 | 6 | NIH | 8/1/2026 | $3,881,976 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | UM1AI164556 | I4C 2.0: Immunotherapy for Cure | 003 | 6 | NIH | 8/1/2026 | $166,667 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | UM1AI164556 | I4C 2.0: Immunotherapy for Cure | 003 | 6 | NIH | 8/1/2026 | $208,333 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | UM1AI164556 | I4C 2.0: Immunotherapy for Cure | 003 | 6 | NIH | 8/1/2026 | $230,000 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | RC2DK116691 | Investigating Human Adipocyte Heterogeneity | 001 | 9 | NIH | 5/6/2026 | $0 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | RC2DK116691 | Investigating Human Adipocyte Heterogeneity | 000 | 9 | NIH | 4/9/2026 | $2,149,635 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL136708 | Use of Registries, Claims and Health System Data to Enhance the Evaluation of Cardiovascular Devices | 000 | 9 | NIH | 8/28/2026 | $714,385 |
|